Persistence Market Research Company
Customize Now Get FREE Sample

Biologics Contract Manufacturing Market Size, Share, and Growth Forecast 2026 - 2033

Biologics Contract Manufacturing Market by Product (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Insulin, Interferons, Growth Factors, Others), by Therapeutic Area (Oncology, Autoimmune Disease, Metabolic Disease, Ophthalmology, Cardiovascular Disease, Infectious Disease, Neurology, Respiratory Disorder, Others), by Application (Hybrid Electric Vehicles, Consumer Electronics, Medical Devices, Industrial Equipment, Power Tools, Emergency Lighting & Backup Power), by End User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes/CROs, Others), by Regional Analysis, 2026-2033

ID: PMRREP31928| 185 Pages | 19 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Biologics Contract Manufacturing Market Snapshot 2026 and 2033
    2. Market Opportunity Assessment, 2026-2033, US$ Bn
    3. Key Market Trends
    4. Industry Developments and Key Market Events
    5. Demand Side and Supply Side Analysis
    6. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definitions
    2. Market Dynamics
      1. Driver
      2. Restraint
      3. Opportunities
      4. Trends
    3. Macro-Economic Factors
      1. Global GDP Outlook
      2. Global Healthcare Expenditure
    4. Forecast Factors – Relevance and Impact
    5. COVID-19 Impact Assessment
  3. Value Added Insights
    1. Value Chain analysis
    2. Key Market Players
    3. Product Adoption Analysis
    4. Key Promotional Strategies by key players
    5. PESTLE Analysis
    6. Porter's Five Forces Analysis
    7. Regulatory and Technology Landscape
  4. Global Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Global Biologics Contract Manufacturing Market Outlook: Product
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Product, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Product, 2026-2033
        1. Monoclonal Antibodies
        2. Recombinant Proteins
        3. Vaccines
        4. Insulin
        5. Interferons
        6. Growth Factors
        7. Others
      4. Market Attractiveness Analysis: Product
    3. Global Biologics Contract Manufacturing Market Outlook: Therapeutic Area
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Therapeutic Area, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
        1. Oncology
        2. Autoimmune Disease
        3. Metabolic Disease
        4. Ophthalmology
        5. Cardiovascular Disease
        6. Infectious Disease
        7. Neurology
        8. Respiratory Disorder
        9. Others
      4. Market Attractiveness Analysis: Therapeutic Area
    4. Global Biologics Contract Manufacturing Market Outlook: Application
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by Application, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by Application, 2026-2033
        1. Hybrid Electric Vehicles (HEVs)
        2. Consumer Electronics
        3. Medical Devices
        4. Industrial Equipment
        5. Power Tools
        6. Emergency Lighting & Backup Power
      4. Market Attractiveness Analysis: Application
    5. Global Biologics Contract Manufacturing Market Outlook: End User
      1. Introduction/Key Findings
      2. Historical Market Size (US$ Bn) Analysis by End User, 2020-2025
      3. Current Market Size (US$ Bn) Forecast, by End User, 2026-2033
        1. Pharmaceutical Companies
        2. Biotechnology Companies
        3. Academic & Research Institutes / CROs
        4. Others
      4. Market Attractiveness Analysis: End User
  5. Global Biologics Contract Manufacturing Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis by Region, 2020-2025
    3. Current Market Size (US$ Bn) Forecast, by Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia & Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. North America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. U.S.
      2. Canada
    3. North America Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. North America Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. North America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. North America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  7. Europe Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Europe Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Germany
      2. Italy
      3. France
      4. U.K.
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Europe Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. Europe Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. Europe Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. Europe Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  8. East Asia Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. East Asia Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. East Asia Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. East Asia Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. East Asia Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. East Asia Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  9. South Asia & Oceania Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. South Asia & Oceania Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of SAO
    3. South Asia & Oceania Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. South Asia & Oceania Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. South Asia & Oceania Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. South Asia & Oceania Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  10. Latin America Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Latin America Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of LATAM
    3. Latin America Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. Latin America Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. Latin America Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. Latin America Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  11. Middle East & Africa Biologics Contract Manufacturing Market Outlook: Historical (2020 – 2025) and Forecast (2026 – 2033)
    1. Key Highlights
    2. Middle East & Africa Market Size (US$ Bn) Forecast, by Country, 2026-2033
      1. GCC Countries
      2. South Africa
      3. Northern Africa
      4. Rest of MEA
    3. Middle East & Africa Market Size (US$ Bn) Forecast, by Product, 2026-2033
      1. Monoclonal Antibodies
      2. Recombinant Proteins
      3. Vaccines
      4. Insulin
      5. Interferons
      6. Growth Factors
      7. Others
    4. Middle East & Africa Market Size (US$ Bn) Forecast, by Therapeutic Area, 2026-2033
      1. Oncology
      2. Autoimmune Disease
      3. Metabolic Disease
      4. Ophthalmology
      5. Cardiovascular Disease
      6. Infectious Disease
      7. Neurology
      8. Respiratory Disorder
      9. Others
    5. Middle East & Africa Market Size (US$ Bn) Forecast, by Application, 2026-2033
      1. Hybrid Electric Vehicles (HEVs)
      2. Consumer Electronics
      3. Medical Devices
      4. Industrial Equipment
      5. Power Tools
      6. Emergency Lighting & Backup Power
    6. Middle East & Africa Market Size (US$ Bn) Forecast, by End User, 2026-2033
      1. Pharmaceutical Companies
      2. Biotechnology Companies
      3. Academic & Research Institutes / CROs
      4. Others
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping
      2. Competition Dashboard
    3. Company Profiles
      1. Samsung Biologics
        1. Company Overview
        2. Product Portfolio/Offerings
        3. Key Financials
        4. SWOT Analysis
        5. Company Strategy and Key Developments
      2. BioXcellence (Boehringer Ingelheim)
      3. Lonza Group AG
      4. Fujifilm Diosynth Biotechnologies
      5. AbbVie CM (AbbVie Inc.)
      6. WuXi Biologics (Cayman) Inc.
      7. AGC Biologics
      8. Patheon N.V. (Thermo Fisher Scientific Inc.)
      9. Emergent BioSolutions Inc.
      10. Ajinomoto Bio-Pharma
      11. Avid Bioservices, Inc.
      12. KBI Biopharma
      13. Rentschler Biotechnologie GmbH
      14. Merck KGaA
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate